Scientific publications

GEC-ESTRO recommendations for head & neck cancer brachytherapy (interventional radiotherapy): 2nd update with focus on HDR and PDR. Scientific Publication

Sep 14, 2024 | Magazine: Radiotherapy Oncology

J L Guinot  1 , W Bacorro  2 , A Budrukkar  3 , F Bussu  4 , V Gonzalez-Perez  5 , R Jaberi  6 , R Martinez-Monge  7 , A Rembielak  8 , A Rovirosa  9 , V Strnad  10 , Z Takácsi-Nagy  11 , L Tagliaferri  12 ; Head & Neck and Skin Working Group of GEC-ESTRO


Abstract

Modern brachytherapy (BT) is playing an important role in the multidisciplinary treatment of Head and Neck (H&N) cancer, as an organ- and function-preserving therapy.

Low-dose-rate (LDR) technology has been replaced by modern remote afterloading and stepping source equipment using pulsed dose rate (PDR) or high dose rate (HDR) sources, improved image guidance and 3D treatment planning systems.

This is an update of the previous GEC-ESTRO recommendations for H&N tumors, mainly applied to squamous carcinomas. Indications, results and recommended doses for different tumor sites are presented according to the published studies.

CITATION  Radiother Oncol. 2024 Sep 14:110533. doi: 10.1016/j.radonc.2024.110533